Shareholders Equity (Annual)

Shareholders Equity: The sum of preferred and common equity items.

Nutex Health Inc. (NUTX) had Shareholders Equity of $201.89M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$479.95M
Net Income	$52.18M
Cost of Goods Sold	$283.69M
Gross Profit	$196.26M
Operating Expenses	$349.33M
Operating Income	$130.62M
Non-Operating Income/Expense	$-20.87M
Pre-Tax Income	$109.75M
Normalized Pre-Tax Income	$109.75M
Income after Taxes	$95.27M
Income from Continuous Operations	$95.27M
Consolidated Net Income/Loss	$95.27M
Normalized Income after Taxes	$95.27M
EBIT	$130.62M
EBITDA	$150.05M
Weighted-Average Shares Outstanding (Basic)	5.09M
Weighted-Average Shares Outstanding (Diluted)	5.37M
Earnings per Share (EPS) (Basic)	$10.25
Earnings per Share (EPS) (Diluted)	$9.71
Balance Sheet Financials
Current Assets	$292.48M
Property, Plant, and Equipment	$77.93M
Long-Term Assets	$362.84M
Total Assets	$655.32M
Current Liabilities	$140.87M
Long-Term Debt	$281.94M
Long-Term Liabilities	$312.56M
Total Liabilities	$453.43M
Common Equity	$201.89M
Tangible Shareholders Equity	$172.44M
Shareholders Equity	$201.89M
Common Shares Outstanding	5.51M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$23.15M
Cash Flow from Investing Activities	$-2.67M
Cash Flow from Financial Activities	$1.09M
Beginning Cash	$22.00M
End Cash	$43.58M
Increase/Decrease in Cash	$21.58M
Stock-Based Compensation	$16.63M
Common Stock Dividends Paid	$-6.44M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.08
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.58
Debt to Equity Ratio	1.52
Gross Margin	40.89%
Operating Margin	27.22%
EBIT Margin	27.22%
EBITDA Margin	31.26%
Pre-Tax Profit Margin	22.87%
Profit Margin	10.87%
Free Cash Flow	$20.85M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.73
Inventory Turnover	99.55
Receiveable Turnover	2.03
Days Sales in Receivables	179.52
Return on Equity	47.19%
Return on Tangible Equity	55.25%
Return on Assets	14.54%
Return on Investments	19.69%
Book Value Per Share	$36.63
Free Cash Flow per Share	$3.88
Operating Cash Flow per Share	$4.31

Data from Zacks Investment Research, Inc.